On March 22, 2023, the United States Health Resources and Services Administration (HRSA), a subset of the HHS, announced plans to overhaul the Organ Procurement and Transplant Network (OPTN). Recently,...
In a study published in Nature on March 15, 2023, researchers achieved complete or nearly complete remission in 18 patients with KMT2A-rearranged or NPMI-mutant leukemia. The phase 1 clinical trial...
In June of 2021, the FDA approved Novo Nordisk’s Wegovy to aid in weight management in overweight adults with weight-related chronic conditions like high blood pressure, type 2 diabetes, or high...
The pharmaceutical supply chain poses risks and challenges to both providers and consumers. But in the context of a health-conscious society, managing pharmaceutical supply chains presents several...
One day into his second term, Governor Gavin Newsom of California has announced a partnership between CalRx, a California Department of Healthcare Services program, and Civica, a healthcare nonprofit,...
On Friday, March 17, 2023, the FDA announced that Scenic Fruit Company has voluntarily recalled some of its frozen fruit sold at Aldi, Trader Joe’s, and Costco. This announcement was just one day...
On March 16, 2023, just days after the FDA approved another new nasal migraine medication, Pfizer recalled its Nurtec ODT medication. Under advisement from the United States Consumer Product Safety...
Insufficient sleep has detrimental effects on vaccine efficacy. A recent meta-analysis published in Current Biology determined that less than six hours of sleep per night resulted in a reduced antibody...
On Monday, the European healthcare company Sanofi announced a $2.9 billion acquisition deal with US-based Provention Bio. Under the terms of the agreement, Sanofi will pay $25 per share in cash,...
By January 2024, Novo Nordisk plans to cut the prices of insulin pens and vials by up to 75%. The company is echoing strategies reported by Eli Lilly earlier this month, attempting to widen access to...
On March 3, 2023, the FDA issued a safety communication, announcing that it would require and approve changes to prescribing information labels for all allergenic extracts. The new labels should...
After speculation about acquisition deals earlier this month, Pfizer Inc has officially confirmed its acquisition of Seagen Inc. The $43 billion deal was a strategic move by Pfizer to expand the...
Last week, Walgreens announced that it would no longer distribute abortion pills in 20 states across the US following legal warnings made by the attorneys general of those states.
Specifically,...
Last week, the FDA added two more eye drops to its recall list: Apotex Corp Brimonidine Tartrate Ophthalmic Solution (0.15%) and Pharmedica USA LLC Purely Soothing 15% MSM Drops. These recalls follow a...
In a recent NIH press release, the organization announced a new study published in Nature Communications analyzing the safety and immunogenicity of a new temperature-stable tuberculosis (TB) vaccine....
Last month, WAND reported that Akorn Pharmaceuticals, a major domestic manufacturer of liquid albuterol, was shutting down. This closure — which followed 2020 reports that the company filed for...
In a recent research letter published in JAMA Network Open, Chris A. Rees, MD, MPH, and his colleagues analyzed how pediatric clinical trial results are disseminated or made publicly available. Rees...
On Wednesday, March 1, 2023, Eli Lilly, a major insulin manufacturer in the United States, announced that it would cut its insulin prices by 70% and cap out-of-pocket costs to $35 per month. By the end...
Pfizer Inc is reportedly in talks to buy the cancer drugmaker Seagen Inc after a potential acquisition by Merck last year fell through. In August 2022, it was reported that Merck was considering a $40...
On February 24, 2023, the United States Drug Enforcement Agency (DEA) issued a press release announcing its proposal for updated telemedicine flexibility rules. At the start of the COVID-19 pandemic...
